Dr. Sharmistha Mishra wins RIC funding for COVID-19 project
With support from donors, Dr. Sharmistha Mishra, an infectious disease physician and mathematical modeller, is designing data-driven and population-specific strategies to flatten the COVID-19 curve in our local communities.
As the COVID-19 pandemic uproots the lives of people everywhere, the global research community is ramping up efforts to find ways to tackle the virus. Scientists at St. Michael’s Hospital were given a boost in the form of funding from St. Michael’s Hospital Foundation’s Research Innovation Council (RIC).
Members of the Council — a group of St. Michael’s Foundation donors who pool their donations and select high-potential research projects to support — usually meet each June to vote on the projects they will fund. But this year their investment meeting was moved up to support science that take on COVID-19 — in the Foundation’s first-ever online event.
The 25 RIC members were given the choice of three game-changing projects. Dr. Sharmistha Mishra and her team are creating a mathematical model to deploy population-specific interventions based on geography and demographics. Dr. Paul Dorian and his team aim to build a simple defibrillator to help COVID-19 patients get more oxygen into their lungs. And Drs. Fahad Razak and Amol Verma plan to use artificial intelligence to reduce the rate of COVID-19 transfer from long-term care to acute care.
After two rounds of intense deliberation, the need for more crucial data won out. Dr. Mishra was awarded $190,000 in funding.
Dr. Mishra is an infectious disease physician whose research focuses on the mathematical modeling of virus transmissions. She and the Research Group in Mathematical Modeling and Program Science will work with colleagues across a number of institutions (including Drs. Stefan Baral, Matthew Muller, Stephen Hwang, Rafal Kustra, Jeff Kwong, Adrienne Chan, and others) to carry out the research.
“We are so grateful to the Foundation for the privilege of supporting the local response in the GTA,” Dr. Mishra says. “The funding will help us produce data-driven, population-specific strategies to flatten the curve in our local communities.”
This is the RIC’s third research grant; the first two winners were Dr. Gaspard Montandon for his work countering opioid addiction and Dr. Sakina Rizvi for her study on the biomarkers of suicide.
The Research Innovation Council offers a donor experience unlike any other and a new way to fund research. RIC members pool their funds and choose the project they want to support. Then they go behind the scenes and inside the lab to see early-stage research, and watch it unfold. And they contribute their skills and business ideas which are crucial to research success. RIC provides the chance to impact some of the most pressing health issues of our time. Join us. Click here to get involved.
Our renowned scientists are at the forefront of the global race to end COVID-19. Support life-saving science by donating to St. Michael’s Power Fund.
St. Michael’s patient first person with MS to play international level rugby league
James Gwatkin has one goal in mind: to quash the stigma associated with Canada’s disease.Read article
SCAR WARS: A world centre for fibrosis research
St. Michael’s is revolutionizing treatment for fibrosis, or organ scarring, the cause of nearly half the deaths in the developed world.Read article
“Women need to make sure they take care of themselves.”
Dr. Beth Abramson’s research throws light on new risk factors of heart disease for younger – and older – women.Read article
A complex pregnancy
St. Michael’s maternal care team goes to the wall to deliver baby Sophia.Read article
Hunting down an antidote to the opioid crisis
Thanks to seed funding from the Research Innovation Council at St. Michael’s Hospital Foundation, Dr. Gaspard Montandon is getting closer to keeping people who need painkillers safe.Read article
“Giving back is who we are.”
In conversation with the Middlefield Group’s Dean Orrico, President and Chief Investment Officer, and Jeremy Brasseur, Managing DirectorRead article